By LawWireNews Detroit, Michigan Dog Bite Injuries Can Include Dog Bite Fatalities
Posted: March 16, 2012 | Author: Lawyer | Filed under: Washington DC Lawyers | Tags: Detroit Lawyers, Dog Bites | Comments Off on By LawWireNews Detroit, Michigan Dog Bite Injuries Can Include Dog Bite FatalitiesWe’ve all been there. Strolling down the road, enjoying a nice afternoon when a dog suddenly comes running down the sidewalk toward us, barking and angry. Or during a bike ride, a dog lunges out from behind a car, snarling and nipping at our heels. Runners encounter dogs all the time, and though most situations don’t become a case of dog bite injuries, some do and every year, in fact, dog bite occur.
The statistics are surprising and, considering that there are dogs in every neighborhood across the country, they’re downright scary as well. In 2010 there were 34 dog attack fatalities and there are over 350,000 dog bite victims each year, with approximately 800,000 requiring some type of medical attention. According to the Centers for Disease Control, between 2001 and 2003 there were 4.5 million dog bite victims per year.
Breaking News New Laws on Texting While Driving Will Likely Affect West Virginia
Posted: March 14, 2012 | Author: Lawyer | Filed under: Auto Accident Lawyer | Tags: News | Comments Off on Breaking News New Laws on Texting While Driving Will Likely Affect West VirginiaIt used to be that applying make-up or slurping coffee from a commuter mug were most common reasons drivers got distracted while behind the wheel. Now, with the number of car accidents going up every year, there is a far more deadly reason people are being distracted: Driving While Texting.
The state of being distracted by texting even has a name: “Intextication”, which can produce the same erratic driving maneuvers that alcohol causes. Some research shows that drunk drivers actual handle their cars more safely than those who are sober but texting. Texting accidents and injuries are on the rise and laws are changing because of it.
The Clinical Pharmacology Regulatory Environment Leaves Room For Lawsuits MAR 2012
Posted: March 10, 2012 | Author: Lawyer | Filed under: Car Accident Lawyers | Tags: big pharma, drug lawsuit, drug recall, drugs, medical malpractice | Comments Off on The Clinical Pharmacology Regulatory Environment Leaves Room For Lawsuits MAR 2012Big Pharma has paid big money to resolve big government investigations over the past 10 years–$8 billion, in fact, according to USA Today’s calculations. That’s no secret to anyone who follows the industry. Nor is it a secret that the companies that found themselves named in Justice Department press releases are still quite happily doing business with Medicare and Medicaid–the very programs they were accused of defrauding.
And it’s no trouble to determine why: If Pfizer ($PFE), which inked the biggest Justice Department settlement so far, were barred from Medicare, for instance, then seniors wouldn’t have easy access to its cancer treatments Aromasin or Sutent, or to its pain drugs Lyrica and Celebrex, or any of the drug giant’s other products. See: paralysis injury lawyer in Fort Worth TX
How to keep companies in line, then? Fines apparently aren’t enough; a Health and Human Services official told USA Today that some drugmakers are under investigation for the second or third time. Corporate integrity agreements are “not sufficient to deter further misconduct,” Gregory Demske, assistant inspector general for HHS, told the paper. And the department’s first attempt to hold individual executives accountable for their companies’ misdeeds backfired.
Two new ideas: HHS could revoke a company’s patent rights as part of a settlement, Demske said, and that approach could start with cases that are under investigation right now. And Sen. Chuck Grassley has introduced a bill that would give the government more options, such as excluding individuals from HHS business even after they’ve left the company involved in a settlement.
But a similar bill in the House is already attracting opposition from pharma, the paper notes. At least a dozen pharma and device companies are lobbying against that bill. As for exclusion, PhRMA says it should only apply to execs who knew about the misconduct and didn’t try to stop it.